News

Funding announcement: Precision Medicine Initiative for Commercialization (preMIC)

The Institute for Precision Medicine (IPM) and sciVelo of the Innovation Institute are soliciting proposals for commercial translation project funding. The IPM facilitates the movement of biomedical research into clinical care. PreMIC focuses specifically on driving translational research projects towards both clinical and commercial application through new company formation, licensing to industry partners, or direct implementation into clinical care by health systems such as UPMC.

News

IPM sponsored Computational Medicine Conference – October 29, 2019

Register now for the Computational Medicine Conference! On Tuesday, October 29, 2019, local and national leaders will gather at the Wyndham Pittsburgh University Center to discuss the use of computational modeling approaches in biomedical research.

Computational methods are permeating all aspects of medicine—from understanding the basic nature of disease, to developing more effective therapeutics, to precisely diagnosing and treating individual patients.

News

Test2Learn™ Investigators Awarded Grant to Accelerate Genomic Testing, Education, and Practice

Test2Learn™ team and University of Pittsburgh faculty members Philip Empey (Pharmacy), Mylynda Massart (Family Medicine), James Stevenson (Pharmacy), and Lisa Parker (Center for Bioethics & Health Law) are leading the work as part of a three-year $2.8 million grant from the Richard King Mellon Foundation awarded to the Institute for Precision Medicine.

The goal of this grant is:

  • to accelerate the adoption of genomic testing through high-fidelity genomics education enabled by Test2Learn
  • to enhance genome sequencing for critically ill infants
  • translate precision medicine research to market

Test2Learn is an award-winning educational solution developed by the University of Pittsburgh School of Pharmacy that embraces participatory education. 

News

Institute for Precision Medicine Receives $2.8 Million Grant from the RK Mellon Foundation

The Institute for Precision Medicine (IPM) at the University of Pittsburgh and UPMC received a three-year $2.8 million grant from the Richard King Mellon Foundation for implementation of precision medicine initiatives, including whole genome sequencing of critically ill infants, genomics education and translational research pilot projects intended for commercialization.

The IPM, a joint effort of Pitt and UPMC,

News

IPM supported research demonstrates clinical impact

A genetic test developed by researchers at the University of Pittsburgh School of Medicine and the Pittsburgh Liver Research Center and partially supported by the 2016 IPM Pilot Program in precision medicine has been published this week in the journal Gut. The test known as ‘Biliseq’ assesses bile duct cacners for actionable genetic markers.

News

New publication from the IPM and Pitt Molecular Biology Information Service

Biomedical researchers are increasingly reliant on obtaining bioinformatics training in order to conduct their research. We recently published a paper discussing how at Pitt we have been making resources available through our Molecular Biology Information Service (MBIS) of the Health Sciences Library System. The MBIS runs a four-facet service with the following goals:

(1) identify, procure and implement commercially licensed bioinformatics software

(2) teach hands-on workshops using bioinformatics tools to solve research questions

(3) provide in-person and email consultations on software/databases

(4) maintain a web portal providing overall guidance on the access and use of bioinformatics resources and MBIS-created webtools.

News

IPM announces pilot award recipients

We had a fantastic response to our two Pilot Programs in Precision Medicine which we announced in December 2018. These pilots support the use of two key University of Pittsburgh/UPMC resources which are vital components in precision medicine research, the Pitt Biospecimen Core (PBC) and the new UPMC Genome Center (UGC).

Congratulations to the investigators and their project teams selected to receive funding through this competitive process.

Uncategorized News

Dr Empey to moderate a session at the Precision Medicine World Leaders Summit 2019

The Institue for Precision Medicine Associate Director of Pharmacogenomics, Philip Empey, PharmD, PhD, will be moderating a session at the Precision Medicine World Leaders Summit East at UPenn School of Medicine, Philadelphia, June 11-12, 2019.

Dr Empey will moderate a discussion on the role of Pharmacogenomics in precision medicine which will take place at 11.20am on June 11th.

News

IPM announce pilot awards to support the use of Pitt Biospecimen Core

The Institute for Precision Medicine (IPM)

Announce Pilot Project Funding in

Support of Human Tissue Requests from the Pitt Biospecimen Core (PBC)

The Institute for Precision Medicine (IPM; www.ipm.pitt.edu) is a collaboration between the University of Pittsburgh and UPMC. The IPM facilitates the movement of precision medicine research into personalized clinical care.

News

New IPM pilot projects announced in support of whole genome sequencing

The Institute for Precision Medicine (IPM)

Announce Pilot Project Funding in

Support of Next Generation Sequencing at the UPMC Genome Center (UGC)

The Institute for Precision Medicine (IPM; www.ipm.pitt.edu) is a collaboration between the University of Pittsburgh and UPMC. The IPM facilitates the movement of precision medicine research into personalized clinical care.

News